Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 12, 2026, 2:07 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 505–528 of 2,608 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Application Use Clear all

Conditions: Advanced Malignant Neoplasm, Dermatologic Complication
Interventions: Doxycycline, Management of Therapy Complications, Placebo, Questionnaire Administration, Spironolactone, Sunscreen, Therapeutic Hydrocortisone; Drug · Procedure · Other
Lead sponsor: Academic and Community Cancer Research United; Other
Eligibility: 18 Years and older
Enrollment: 19 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2014
U.S. locations: 5
States / cities: Urbana, Illinois • Des Moines, Iowa • Wichita, Kansas + 2 more

Conditions: Total Knee Arthroplasty
Interventions: CyMedica e-vive™ System; CY-1000, iGetBetter telemedicine physical therapy; Device · Other
Lead sponsor: Wolfgang Fitz, M.D.; Other
Eligibility: 18 Years and older
Enrollment: 21 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2022
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Intraoperative Bleeding, Liver Diseases, Gallbladder Diseases, Hemorrhage, Surgical
Interventions: GATT-Patch, SURGICEL® Original; Device
Lead sponsor: GATT Technologies BV; Industry
Eligibility: 22 Years and older
Enrollment: 53 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2025
U.S. locations: 6
States / cities: Los Angeles, California • St Louis, Missouri • Pennington, New Jersey + 3 more

Conditions: Opioid-use Disorder, Opioid Dependence, Opioid Use
Interventions: Discharge Order Sets, Pharmacist-Led Discharge Counseling and Communication, Post-discharge Pain Management Follow-up, Patient Engagement Pain Management App; Behavioral
Lead sponsor: Brigham and Women's Hospital; Other
Eligibility: 18 Years and older
Enrollment: 204 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2024
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Prematurity; Extreme
Interventions: Near-infrared spectroscopy (NIRS) utilization; Device
Lead sponsor: University of New Mexico; Other
Eligibility: 0 Hours to 24 Hours
Enrollment: 21 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2023
U.S. locations: 1
States / cities: Albuquerque, New Mexico

Conditions: Sleep
Interventions: Fibit + Coaching, Coaching, Fitbit; Behavioral
Lead sponsor: University of Utah; Other
Eligibility: 25 Years to 65 Years
Enrollment: 45 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2020
U.S. locations: 1
States / cities: Salt Lake City, Utah

Conditions: Lack of Keratinized Gingiva
Interventions: L-PRF (Leucocyte- platelet rich fibrin), H-PRF (Horizontal -platelet rich fibrin), Surgical stent; Biological · Device
Lead sponsor: Abdo Y Ismail; Other
Eligibility: 18 Years to 65 Years
Enrollment: 30 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2023
U.S. locations: 1
States / cities: Lexington, Kentucky

Conditions: Diabetic Foot, Foot Ulcer, Diabetic
Interventions: Santyl, Product containing silver; Biological · Other
Lead sponsor: Smith & Nephew, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 102 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2017
U.S. locations: 11
States / cities: Sylmar, California • Melbourne, Florida • Baltimore, Maryland + 8 more

Conditions: PreDiabetes
Interventions: Noom Coach DPP; Behavioral
Lead sponsor: Noom Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 202 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2018
U.S. locations: 1
States / cities: Stony Brook, New York

Conditions: Breast Reconstruction, Perfusion; Complications, High Risk for Breast Cancer, Genetic Predisposition
Interventions: Minoxidil, Hair mousse; Drug
Lead sponsor: Duke University; Other
Eligibility: 18 Years and older · Female only
Enrollment: 25 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Facial Paralysis
Interventions: Mindfulness Meditation Phone Application; Behavioral
Lead sponsor: Johns Hopkins University; Other
Eligibility: 18 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2022
U.S. locations: 2
States / cities: Baltimore, Maryland • Lutherville-Timonium, Maryland

Conditions: Open Abdomen After Damage Control Laparotomy
Interventions: Primary Fascial Closure, wound vac dressing application; Procedure · Device
Lead sponsor: San Antonio Military Medical Center; Federal
Eligibility: 18 Years and older
Enrollment: 312 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2017
U.S. locations: 1
States / cities: San Antonio, Texas

Conditions: Acne
Interventions: IDP-120 Gel; Drug
Lead sponsor: Bausch Health Americas, Inc.; Industry
Eligibility: 9 Years to 17 Years
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016
U.S. locations: 1
States / cities: Austin, Texas

Conditions: Vulvar Cancer
Interventions: imiquimod, biopsy, therapeutic conventional surgery; Drug · Procedure
Lead sponsor: Memorial Sloan Kettering Cancer Center; Other
Eligibility: 18 Years and older · Female only
Enrollment: 8 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2018
U.S. locations: 2
States / cities: New York, New York • Columbus, Ohio

Conditions: Injection Fear, Injection Pain Prevention, Injection Complication
Interventions: Ethyl Chloride, Cold Saline Spray; Other
Lead sponsor: University of Chicago; Other
Eligibility: 18 Years and older
Enrollment: 246 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2028
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Acne Vulgaris
Interventions: dapsone gel; Drug
Lead sponsor: Almirall, S.A.; Industry
Eligibility: 9 Years to 11 Years
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2018
U.S. locations: 20
States / cities: Birmingham, Alabama • Fremont, California • Northridge, California + 17 more

Conditions: Spinal Cord Injuries (SCI), Multiple Sclerosis
Interventions: Individualized reduction of falls (iROLL), Stopping Elderly Accidents, Deaths & Injuries (STEADI); Procedure
Lead sponsor: University of Illinois at Urbana-Champaign; Other
Eligibility: 18 Years and older
Enrollment: 120 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: Urbana, Illinois

Conditions: Cocaine Use Disorder, Cocaine Dependence, Substance Use Disorder (SUD), Opioid Use Disorder, Opioid Dependence
Interventions: Transcranial Direct Current Stimulator (tDCS), Cognitive Reappraisal Training; Device · Behavioral
Lead sponsor: Icahn School of Medicine at Mount Sinai; Other
Eligibility: 18 Years to 60 Years
Enrollment: 240 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2030
U.S. locations: 1
States / cities: New York, New York

Conditions: High Blood Glucose, High Cholesterol, High Cholesterol/Hyperlipidemia, Blood Sugar; High, Obesity & Overweight, Diabetes Type 2
Interventions: FELLAship; Behavioral
Lead sponsor: University of Alabama at Birmingham; Other
Eligibility: 18 Years and older · Male only
Enrollment: 90 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Birmingham, Alabama

Conditions: Childhood Obesity, Cardiovascular Disease Prevention
Interventions: In-home Visits and Food Preparation Activities, Ecological Momentary Intervention, Feedback on Video-recorded Family Meals, Maintenance; Behavioral
Lead sponsor: University of Colorado, Denver; Other
Eligibility: 5 Years to 10 Years
Enrollment: 500 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2028
U.S. locations: 2
States / cities: Aurora, Colorado • Minneapolis, Minnesota

Conditions: Pressure Ulcers, Spinal Cord Injury
Interventions: HP011-101 (Xenaderm Ointment), Standard Care; Drug
Lead sponsor: Healthpoint; Industry
Eligibility: 12 Years and older
Enrollment: 19 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2013
U.S. locations: 5
States / cities: Long Beach, California • San Jose, California • Tampa, Florida + 2 more

Conditions: Opioid-use Disorder, Contingency Management, Medication for Opioid-use Disorder
Interventions: Software Application; Other
Lead sponsor: Q2i, LLC; Industry
Eligibility: 18 Years and older
Enrollment: 26 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2021
U.S. locations: 1
States / cities: Worcester, Massachusetts

Conditions: Pain, Chronic, Pain, Chronic Post-Surgical
Interventions: iCanCope Post Op Application; Behavioral
Lead sponsor: The Hospital for Sick Children; Other
Eligibility: 12 Years to 18 Years
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2026
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Acne, Post Inflammatory Hyperpigmentation
Interventions: Liftactiv B3, Sunscreen; Drug · Other
Lead sponsor: University of Miami; Other
Eligibility: 18 Years to 50 Years
Enrollment: 13 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2023
U.S. locations: 1
States / cities: Miami, Florida

Search by objective public record fields.

Spironolactone in Preventing Rash in Patients With Advanced Cancer Receiving Panitumumab and Cetuximab

Is There an Alternative to Immediate Home Physical Therapy Following Total Knee Arthroplasty

GATT-Patch Versus SURGICEL® Original in Minimally Invasive Liver and Gallbladder Surgery

Prevention of Opioid Use Disorder After Surgery

Use of NIRS in Preterm Population Born at Altitude

Randomized Experiment of Sleep Technology

The Clinical Impact of L-PRF, H-PRF or the Use of Surgical Stent on Palatal Donor Site Healing.

Use of Santyl in Diabetic Foot Ulcers

Prevention of Diabetes Using Mobile-enabled, Virtual Delivery of the National Diabetes Prevention Program

Assessment of Topical Minoxidil on Intraoperative Flap Perfusion and Cutaneous Flap Viability in Breast Recon

Effects of Mindfulness Meditation on Facial Paralysis Patients

Use of Hypertonic Saline After Damage Control Laparotomy to Improve Early Primary Fascial Closure

Absorption and Systematic Pharmacokinetics of Topically Applied IDP-120 Gel

Topical Imiquimod in Treating Patients With Recurrent Paget's Disease of the Vulva

Does Ethyl Chloride Spray Work?

Safety and Efficacy Trial of ACZONE (Dapsone) Gel, 7.5% in 9 to 11 Year-Old Patients With Acne Vulgaris

Fall Prevention Among People With Spinal Cord Injury and Multiple Sclerosis Who Use Wheelchairs and Scooters

Transcranial Direct Current Stimulation (tDCS) for Treatment of Substance Use Disorder

FELLAShip to Better Health

Family Matters Intervention

Comparison of HP011-101 to Standard Care for Stage I-II Pressure Ulcers in Subjects With Spinal Cord Injury

Usability Testing for the Reward-based Technology to Improve OUD Treatment

iCanCope With Post-Operative Pain (iCanCope PostOp)

LiftActiv B3 in Post Inflammatory Hyperpigmentation (PIHP)